300142 沃森生物
已收盘 11-10 15:00:00
资讯
新帖
简况
沃森生物新提交“WalSynaix”商标注册申请
证券之星 · 11-07 21:57
沃森生物新提交“WalSynaix”商标注册申请
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
证券之星 · 11-04
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
沃森生物：调整增值税税率叠加市场环境变化影响业绩
证券之星 · 11-04
沃森生物：调整增值税税率叠加市场环境变化影响业绩
沃森生物：公司境外销售涉及外币结算
证券之星 · 11-04
沃森生物：公司境外销售涉及外币结算
沃森生物（300142）披露2026年三季度报告，10月30日股价下跌5.39%
证券之星 · 10-30
沃森生物（300142）披露2026年三季度报告，10月30日股价下跌5.39%
10月30日沃森生物跌5.39%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 10-30
10月30日沃森生物跌5.39%，招商国证生物医药指数(LOF)C基金重仓该股
图解沃森生物三季报：第三季度单季净利润同比下降138.79%
证券之星 · 10-30
图解沃森生物三季报：第三季度单季净利润同比下降138.79%
10月29日沃森生物跌5.42%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 10-29
10月29日沃森生物跌5.42%，招商国证生物医药指数(LOF)C基金重仓该股
沃森生物（300142）10月19日主力资金净卖出6762.51万元
证券之星 · 10-20
沃森生物（300142）10月19日主力资金净卖出6762.51万元
沃森生物（300142）10月14日主力资金净卖出1.12亿元
证券之星 · 10-15
沃森生物（300142）10月14日主力资金净卖出1.12亿元
沃森生物：公司本次向特定对象发行股票尚需通过深交所审核
证券之星 · 10-15
沃森生物：公司本次向特定对象发行股票尚需通过深交所审核
沃森生物(300142.SZ)：冻干带状疱疹病毒mRNA疫苗启动I期临床试验
智通财经 · 10-14
沃森生物(300142.SZ)：冻干带状疱疹病毒mRNA疫苗启动I期临床试验
沃森生物：冻干带状疱疹病毒mRNA疫苗正式启动I期临床试验
格隆汇 · 10-14
沃森生物：冻干带状疱疹病毒mRNA疫苗正式启动I期临床试验
沃森生物（300142）10月12日主力资金净卖出1.68亿元
证券之星 · 10-13
沃森生物（300142）10月12日主力资金净卖出1.68亿元
沃森生物（300142）10月9日主力资金净买入1.65亿元
证券之星 · 10-12
沃森生物（300142）10月9日主力资金净买入1.65亿元
沃森生物：公司已于9月23日向深交所报送了关于深交所对公司向特定对象发行股票事项的问询函的回函
证券之星 · 10-08
沃森生物：公司已于9月23日向深交所报送了关于深交所对公司向特定对象发行股票事项的问询函的回函
9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 09-30
9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股
沃森生物：公司向特定对象发行股票申请文件已获得深交所受理
证券之星 · 09-18
沃森生物：公司向特定对象发行股票申请文件已获得深交所受理
沃森生物：新型冠状病毒mRNA疫苗获药品注册证书
证券之星 · 09-18
沃森生物：新型冠状病毒mRNA疫苗获药品注册证书
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
证券之星 · 09-15
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
加载更多
公司概况
公司名称：
云南沃森生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2010-11-12
主营业务：
云南沃森生物技术股份有限公司的主营业务是人用疫苗等生物技术药的研发、生产和销售。公司的主要产品是疫苗产品。
发行价格：
95.00
{"stockData":{"symbol":"300142","market":"SZ","secType":"STK","nameCN":"沃森生物","latestPrice":11.36,"timestamp":1794294204000,"preClose":11.31,"halted":0,"volume":22655706,"delay":0,"changeRate":0.0044,"floatShares":1578000000,"shares":1599000000,"eps":0.0137,"marketStatus":"已收盘","change":0.05,"latestTime":"11-10 15:00:00","open":11.47,"high":11.49,"low":11.26,"amount":257000000,"amplitude":0.0203,"askPrice":11.37,"askSize":1143,"bidPrice":11.36,"bidSize":399,"shortable":0,"etf":0,"ttmEps":0.0137,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.31,"symbolType":"stock","openAndCloseTimeList":[[1794274200000,1794281400000],[1794286800000,1794294000000]],"highLimit":12.44,"lowLimit":10.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1599348541,"isCdr":false,"pbRate":2.61,"roa":"--","peRate":829.19708,"roe":"0.1%","epsLYR":0.1111,"committee":-0.214209,"marketValue":18169000000,"turnoverRate":0.0144,"status":0,"floatMarketCap":17924000000},"requestUrl":"/m/hq/s/300142","defaultTab":"news","newsList":[{"id":"2681810838","title":"沃森生物新提交“WalSynaix”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2681810838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681810838?lang=zh_cn&edition=full","pubTime":"2026-11-07 21:57","pubTimestamp":1794059831,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日云南沃森生物技术股份有限公司新提交“WalSynaix”商标注册申请。商标申请详情如下：今年以来云南沃森生物技术股份有限公司新申请注册商标159件，截止目前公司共持有注册商标330件，另有243件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700018902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300142","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680051456","title":"沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680051456?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:52","pubTimestamp":1793796752,"startTime":"0","endTime":"0","summary":"公司九价HPV疫苗目前处于III期临床研究阶段，公司将按照国家对于疫苗注册临床试验的有关程序和要求推进在研疫苗产品的相关工作，在达到相应节点时通过正式公告予以披露。二价HPV疫苗集采落地后的经营影响，涉及对未来收入及毛利的评估，具体数据请以公司定期报告披露为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400038822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159646","BK0239","300142","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088223","title":"沃森生物：调整增值税税率叠加市场环境变化影响业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088223?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:36","pubTimestamp":1793763407,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物11月03日在投资者关系平台上答复投资者关心的问题。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400017051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0077","300142","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088711","title":"沃森生物：公司境外销售涉及外币结算","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088711?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:36","pubTimestamp":1793763366,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物11月03日在投资者关系平台上答复投资者关心的问题。是否影响收入沃森生物回复：尊敬的投资者，您好，感谢您的关注。公司境外销售涉及外币结算，汇率波动可能对相关财务数据产生一定影响，影响程度受结算币种、结算时点及结算安排等多种因素影响。公司将持续关注汇率变动情况，并结合业务实际做好相应管理，具体影响请以公司定期报告披露的数据为准，感谢您的理解与支持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400016989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0070","300142","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679215237","title":"沃森生物（300142）披露2026年三季度报告，10月30日股价下跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679215237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679215237?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:37","pubTimestamp":1793360272,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，沃森生物报收于10.89元，较前一交易日下跌5.39%，最新总市值为174.17亿元。该股当日开盘10.86元，最高11.4元，最低10.8元，成交额达7.05亿元，换手率为4.04%。沃森生物于2026年10月30日披露《2026年三季度报告》。报告显示，本报告期营业收入312,701,965.56元，同比下降44.61%；归属于上市公司股东的净利润-46,655,234.17元，同比下降138.79%。年初至报告期末营业收入1,146,917,150.37元，同比下降33.27%；归属于上市公司股东的净利润7,536,960.37元，同比下降95.39%。基本每股收益0.0047元，同比下降95.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0070","300142","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679829659","title":"10月30日沃森生物跌5.39%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679829659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679829659?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:15","pubTimestamp":1793351738,"startTime":"0","endTime":"0","summary":"证券之星消息，10月30日沃森生物跌5.39%创60日新低，收盘报10.89元，换手率4.04%，成交量63.81万手，成交额7.05亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000042075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","300142","BK0070","BK0239","399441","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679236312","title":"图解沃森生物三季报：第三季度单季净利润同比下降138.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679236312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679236312?lang=zh_cn&edition=full","pubTime":"2026-10-30 04:05","pubTimestamp":1793304352,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物2026年三季报显示，前三季度公司主营收入11.47亿元，同比下降33.27%；归母净利润753.7万元，同比下降95.39%；扣非净利润4673.73万元，同比下降33.74%；其中2026年第三季度，公司单季度主营收入3.13亿元，同比下降44.61%；单季度归母净利润-4665.52万元，同比下降138.79%；单季度扣非净利润-4820.75万元，同比下降214.51%；负债率30.23%，投资收益367.89万元，财务费用2263.74万元，毛利率66.69%。财报数据概要请见下图:本文数据来源于沃森生物2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000006002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679285475","title":"10月29日沃森生物跌5.42%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679285475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679285475?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:59","pubTimestamp":1793264355,"startTime":"0","endTime":"0","summary":"证券之星消息，10月29日沃森生物跌5.42%创60日新低，收盘报11.51元，换手率3.36%，成交量53.09万手，成交额6.24亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900041049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0070","BK0077","BK0239","399441","BK0046","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676363079","title":"沃森生物（300142）10月19日主力资金净卖出6762.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676363079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676363079?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:18","pubTimestamp":1792459097,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，沃森生物报收于12.85元，下跌3.17%，换手率4.27%，成交量67.32万手，成交额8.65亿元。近5日资金流向一览见下表：沃森生物融资融券信息显示，融资方面，当日融资买入9493.76万元，融资偿还8726.3万元，融资净买入767.46万元。融券方面，融券卖出1.38万股，融券偿还8600.0股，融券余量92.01万股，融券余额1182.33万元。沃森生物主营业务：从事人用疫苗等生物技术药集研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000006478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0239","300142","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675037936","title":"沃森生物（300142）10月14日主力资金净卖出1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675037936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675037936?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:14","pubTimestamp":1792026899,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，沃森生物报收于13.35元，下跌5.18%，换手率5.15%，成交量81.19万手，成交额11.03亿元。近5日资金流向一览见下表：沃森生物融资融券信息显示，融资方面，当日融资买入1.31亿元，融资偿还1.03亿元，融资净买入2830.61万元，连续3日净买入累计1.1亿元。沃森生物主营业务：从事人用疫苗等生物技术药集研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","BK0077","300142","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675721375","title":"沃森生物：公司本次向特定对象发行股票尚需通过深交所审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2675721375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675721375?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:36","pubTimestamp":1792024569,"startTime":"0","endTime":"0","summary":"公司已于9月23日向深交所报送了关于深交所对公司向特定对象发行股票事项的问询函的回函并同步在巨潮资讯网披露了回函内容，同时按照相关规定对募集说明书等发行申请文件的内容进行了更新和披露，具体内容请查阅公司在巨潮资讯网披露的相关公告。公司本次向特定对象发行股票尚需通过深交所审核，并获得中国证监会同意注册的批复后方可实施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500007237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0070","BK0239","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675034494","title":"沃森生物(300142.SZ)：冻干带状疱疹病毒mRNA疫苗启动I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2675034494","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675034494?lang=zh_cn&edition=full","pubTime":"2026-10-14 20:34","pubTimestamp":1791981274,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沃森生物(300142.SZ)发布公告，由公司子公司北京沃森创新生物技术有限公司、云南疫苗实验室有限公司、玉溪沃森生物技术有限公司与复旦大学、上海蓝鹊生物医药有限公司(简称“蓝鹊生物”)联合研发的冻干带状疱疹病毒mRNA疫苗已完成I期临床试验准备工作，于今日召开了I期临床试验启动会，正式启动I期临床试验工作。该疫苗启动I期临床试验是本疫苗研发过程中取得的阶段性进展，公司将积极推动疫苗的临床研究工作，若该疫苗研发成功，将进一步丰富公司在mRNA疫苗领域及成人疫苗领域的产品布局，为公司长远持续稳健发展奠定坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300142","BK0046","BMED","IBBQ","MRNX","IBBJ","BK0239","MDTX","BK0077","PSYK","BK0070","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675731046","title":"沃森生物：冻干带状疱疹病毒mRNA疫苗正式启动I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2675731046","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675731046?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:47","pubTimestamp":1791971252,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300142","BK0046","BK0077","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675389719","title":"沃森生物（300142）10月12日主力资金净卖出1.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675389719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675389719?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:19","pubTimestamp":1791854390,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，沃森生物报收于14.05元，下跌4.75%，换手率6.66%，成交量105.16万手，成交额15.12亿元。近5日资金流向一览见下表：沃森生物融资融券信息显示，融资方面，当日融资买入1.8亿元，融资偿还1.14亿元，融资净买入6569.97万元，连续3日净买入累计1.44亿元。沃森生物主营业务：从事人用疫苗等生物技术药集研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300008591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0077","300142","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674847372","title":"沃森生物（300142）10月9日主力资金净买入1.65亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674847372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674847372?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:07","pubTimestamp":1791767271,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，沃森生物报收于14.75元，上涨4.76%，换手率9.4%，成交量148.34万手，成交额21.2亿元。近5日资金流向一览见下表：沃森生物融资融券信息显示，融资方面，当日融资买入1.92亿元，融资偿还1.72亿元，融资净买入1954.35万元。沃森生物主营业务：从事人用疫苗等生物技术药集研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200002910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0046","BK0239","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027652","title":"沃森生物：公司已于9月23日向深交所报送了关于深交所对公司向特定对象发行股票事项的问询函的回函","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027652?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:42","pubTimestamp":1791448936,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物10月08日在投资者关系平台上答复投资者关心的问题。如此儿戏的定增方案，限定价格限定发行股票数，设置上限有没有抑制股价沃森生物回复：尊敬的投资者，您好！公司已于9月23日向深交所报送了关于深交所对公司向特定对象发行股票事项的问询函的回函并同步在巨潮资讯网披露了回函内容，同时按照相关规定对募集说明书等发行申请文件的内容进行了更新和披露，具体内容请查阅公司在巨潮资讯网披露的相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300142","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274469","title":"9月30日沃森生物涨5.49%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671274469?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:38","pubTimestamp":1790757521,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日沃森生物涨5.49%，收盘报14.23元，换手率9.73%，成交量153.56万手，成交额21.83亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000026014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","399441","BK0077","300142","BK0070","161726","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668292925","title":"沃森生物：公司向特定对象发行股票申请文件已获得深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2668292925","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668292925?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735698,"startTime":"0","endTime":"0","summary":"公司于2026年8月27日收到深圳证券交易所出具的《关于受理云南沃森生物技术股份有限公司向特定对象发行股票申请文件的通知》，本次发行项目的申请文件已获得深交所受理。鉴于本次发行事项尚在持续推进中，本次向特定对象发行股票事项最终能否通过深交所审核，并获得中国证监会同意注册的批复及其时间尚存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300142","BK0239","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668460719","title":"沃森生物：新型冠状病毒mRNA疫苗获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668460719","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668460719?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:21","pubTimestamp":1789719668,"startTime":"0","endTime":"0","summary":"公司基于mRNA平台技术策略迭代开发的新型冠状病毒mRNA疫苗已于2026年9月10日收到《药品注册证书》。另有呼吸道合胞病毒mRNA疫苗、冻干带状疱疹病毒mRNA疫苗已获得《药物临床试验批准通知书》，正在开展I期临床试验准备相关工作。关于公司mRNA技术平台及具体产品的研发进展，请您查阅公司在巨潮资讯网披露的定期报告及相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800024134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0239","300142","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667941766","title":"沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2667941766","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667941766?lang=zh_cn&edition=full","pubTime":"2026-09-15 08:27","pubTimestamp":1789432024,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物(300142)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司九价hpv疫苗数据整理要多久才能整理好提交审批沃森生物回复：尊敬的投资者，您好！感谢您对公司的关注。公司九价HPV疫苗目前处于III期临床研究阶段，公司将按照国家对于疫苗注册临床试验的有关程序和要求推进在研疫苗产品的相关工作，有关信息请持续关注公司后续披露的公告和定期报告。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500006267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","159646","300142","BK0046","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794316033778,"stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":-0.2332},{"period":"3month","weight":-0.1425},{"period":"6month","weight":-0.2322},{"period":"1year","weight":-0.0673},{"period":"ytd","weight":0.0498}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.0695},{"period":"6month","weight":-0.1371},{"period":"1year","weight":-0.0842},{"period":"ytd","weight":-0.0776}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南沃森生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"164168人(较上一季度增加25.36%)","perCapita":"9611股","listingDate":"2010-11-12","address":"云南省昆明市五华区高新区科新路395号","registeredCapital":"159934万元","survey":" 云南沃森生物技术股份有限公司的主营业务是人用疫苗等生物技术药的研发、生产和销售。公司的主要产品是疫苗产品。","listedPrice":95},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沃森生物(300142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沃森生物(300142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沃森生物,300142,沃森生物股票,沃森生物股票老虎,沃森生物股票老虎国际,沃森生物行情,沃森生物股票行情,沃森生物股价,沃森生物股市,沃森生物股票价格,沃森生物股票交易,沃森生物股票购买,沃森生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沃森生物(300142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沃森生物(300142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}